دورية أكاديمية

Is Cardiopulmonary Exercise Testing Predictive of Surgical Complications in Patients Undergoing Surgery for Ovarian Cancer?

التفاصيل البيبلوغرافية
العنوان: Is Cardiopulmonary Exercise Testing Predictive of Surgical Complications in Patients Undergoing Surgery for Ovarian Cancer?
المؤلفون: Smits, Anke, Agius, Claire-Marie, Blake, Dominic, Ang, Christine, Kucukmetin, Ali, Ham, Maaike van, Pijnenborg, Johanna M. A., Knight, Joanne, Rundle, Stuart
المصدر: Cancers; Nov2023, Vol. 15 Issue 21, p5185, 12p
مصطلحات موضوعية: EXERCISE tests, LENGTH of stay in hospitals, PREOPERATIVE care, PREDICTIVE tests, OVARIAN tumors, CARDIOPULMONARY system, CARDIOPULMONARY fitness, OXYGEN consumption, SURGICAL complications, SURGERY, PATIENTS, RETROSPECTIVE studies, PATIENT readmissions, RISK assessment, TREATMENT effectiveness, TUMOR markers, SENSITIVITY & specificity (Statistics), LONGITUDINAL method, DISEASE risk factors, EVALUATION
مستخلص: Simple Summary: Treatment of ovarian cancer often involves extensive surgery and is associated with an increased risk of surgical complications. Cardiopulmonary exercise testing (CPET) is a tool used to assess patients' cardiac and respiratory fitness, and the patient's ability to withstand the rigor of extensive surgery. Cardiorespiratory fitness is recognised as a predictive tool for surgical complications in many surgical specialities but has not yet been assessed in ovarian cancer patients. The aim of our retrospective study was to evaluate the value of CPET in predicting surgical complications in ovarian cancer surgery. In addition, we assessed the relationship between cardiorespiratory fitness and other outcomes such as hospital stay, readmission and resectability of disease. We found that patients with a raised VE/VCO2 observed during CPET, experienced more surgical complications. However, we did not find a relationship with other outcomes. Future studies are needed to further delineate the predictive value of CPET in this population. Preoperative cardiopulmonary exercise testing (CPET) provides an objective assessment of functional capability. In other intra-abdominal surgical specialties, CPET outcomes are predictive of operative morbidity. However, in ovarian cancer surgery, its predictive value remains unknown. In this study, we evaluated the association between CPET performance and surgical morbidity in ovarian cancer patients. Secondly, we assessed the association between CPET performance and other surgical outcomes (i.e., hospital stay, readmission and residual disease). This was a retrospective cohort study of patients undergoing primary surgery for ovarian cancer between 2020 and 2023. CPET performance included peak oxygen uptake (VO2 max), ventilatory efficiency (VE/VO2) and anaerobic threshold. Outcomes were operative morbidity and included intra- and postoperative complications (Clavien–Dindo), hospital stay, readmission within 30 days and residual disease. A total of 142 patients were included. A lower VO2 peak and a higher VE/VCO2 were both associated with the occurrence of postoperative complications, and a poorer anaerobic threshold was associated with more transfusions. VE/VCO2 remained significantly associated after multivariate analysis (p = 0.035). None of the CPET outcomes were associated with length of stay, readmission or residual disease. In conclusion, VE/VCO2 was significantly associated with an increased risk of all-cause postoperative complications in ovarian cancer patients undergoing primary surgery. [ABSTRACT FROM AUTHOR]
Copyright of Cancers is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:20726694
DOI:10.3390/cancers15215185